GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » Policyholder Funds

Biocure Technology (XCNQ:CURE) Policyholder Funds


View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Biocure Technology Business Description

Traded in Other Exchanges
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
Biocure Technology Inc is a biopharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.
Executives
Konstantin Lichtenwald Director, Senior Officer